USANA Health Sciences, Inc. (USNA)
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
$14.96+3.67%
Close 2026-09-04 · 1-day change
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
QuarterlyIQ Insights · USNA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | FY 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | — | 925.3 | 925.3 | 854.5 | 921.0 | 998.6 | 1,134.6 | — | 1,060.9 | 1,189.2 | 1,047.3 | 1,006.1 | 918.5 | 790.5 | 718.2 | 648.7 | 581.9 |
| Total Revenues | — | — | — | — | — | — | — | — | 1,060.9 | 1,189.2 | — | — | — | — | — | — | — |
| Cost of Revenues | — | 200.9 | 200.9 | 161.2 | 176.7 | 193.9 | 209.1 | — | 187.5 | 200.7 | — | — | — | — | — | — | — |
| Gross Profit | — | 724.4 | 724.4 | 693.3 | 744.3 | 804.7 | 925.5 | — | 873.4 | 988.5 | 867.9 | 825.9 | 758.8 | 649.7 | 590.7 | 532.9 | 480.2 |
| Operating Expenses & Income | |||||||||||||||||
| Selling, General & Admin | — | 337.4 | 337.4 | 263.3 | 257.0 | 262.3 | 261.2 | — | 267.7 | 275.1 | 265.1 | 234.2 | 209.0 | 184.5 | 166.2 | 154.2 | 137.1 |
| R&D Expenses | — | 10.7 | 10.7 | 11.6 | 11.4 | 11.6 | 10.6 | — | 10.3 | 10.2 | 9.0 | 8.8 | 6.4 | 5.1 | 5.1 | 4.7 | — |
| Operating Income | — | 37.4 | 37.4 | 66.3 | 93.1 | 107.6 | 176.5 | — | 146.2 | 188.4 | 132.5 | 138.6 | 141.7 | 116.1 | 116.7 | 98.2 | 77.3 |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | — | — | 0.8 | — | 0.3 | 0.2 | 0.5 | — | 0.1 | 0.0 | 0.0 | 0.4 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Interest & Investment Income | — | 2.4 | 2.4 | 11.3 | 9.6 | 3.8 | 2.5 | — | 4.7 | 4.4 | 2.2 | 1.5 | 1.1 | 0.5 | 0.5 | 0.2 | 0.2 |
| Net Interest Expenses | — | — | — | — | (9.4) | (3.6) | (2.0) | — | (4.6) | (4.4) | (2.1) | (1.0) | (1.1) | (0.4) | (0.5) | (0.2) | (0.2) |
| Other Non-Operating Income / Expenses | — | 4.1 | 4.1 | 10.0 | 9.4 | 1.0 | 1.5 | — | 4.3 | 3.2 | 2.1 | (0.1) | 0.9 | (0.4) | (0.1) | 0.2 | 0.2 |
| Asset Writedown | — | — | — | — | — | — | — | — | 2.7 | 2.7 | 2.7 | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | 41.5 | 41.5 | 76.4 | 102.5 | 108.6 | 177.9 | — | 150.5 | 191.5 | 134.6 | 138.6 | 142.6 | 115.7 | 116.6 | 98.4 | 77.5 |
| Income Tax Expense | — | 30.1 | 30.1 | 34.3 | 38.7 | 39.3 | 53.3 | — | 50.0 | 65.3 | 72.1 | 38.5 | 47.9 | 39.0 | 37.6 | 32.0 | 26.7 |
| Net Income | |||||||||||||||||
| Net Income | — | 10.8 | 10.8 | 42.0 | 63.8 | 69.4 | 124.7 | — | 100.5 | 126.2 | 62.5 | 100.0 | 94.7 | 76.6 | 79.0 | 66.4 | 50.8 |
| Per Share | |||||||||||||||||
| Basic EPS | — | 0.58 | 0.58 | 2.20 | 3.31 | 3.60 | 5.89 | — | 4.44 | 5.24 | 2.57 | 4.14 | 3.72 | 2.90 | 5.77 | 4.57 | 3.30 |
| Diluted EPS | — | 0.58 | 0.58 | 2.19 | 3.30 | 3.59 | 5.86 | — | 4.41 | 5.12 | 2.53 | 3.99 | 3.59 | 2.80 | 5.56 | 4.45 | 3.26 |
| Basic Weighted Avg Shares | 18.5 | 18.5 | 18.5 | 19.1 | 19.3 | 19.3 | 21.2 | — | 22.6 | 24.1 | 24.3 | 24.2 | 25.5 | 26.4 | 13.7 | 14.5 | 15.4 |
| Diluted Weighted Avg Shares | 18.5 | 18.6 | 18.6 | 19.2 | 19.3 | 19.3 | 21.3 | — | 22.8 | 24.6 | 24.7 | 25.0 | 26.4 | 27.4 | 14.2 | 14.9 | 15.6 |
| Supplemental | |||||||||||||||||
| EBITDA | — | 70.0 | 70.0 | 80.9 | 105.8 | 121.0 | 190.2 | — | 160.9 | 205.2 | 148.6 | 152.1 | 151.6 | 124.9 | 125.8 | 107.0 | 85.7 |
| EBIT | — | 37.4 | 37.4 | 66.3 | 93.1 | 107.6 | 176.5 | — | 146.2 | 188.4 | 132.5 | 138.6 | 141.7 | 116.1 | 116.7 | 98.2 | 77.3 |
| Effective Tax Rate | — | 72.4% | — | 44.9% | 37.7% | 36.2% | 29.9% | — | 33.2% | 34.1% | 53.6% | 27.8% | 33.6% | 33.7% | 32.2% | 32.5% | 34.5% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.